1-(3-Chlorophenyl)piperazine → HCID 12686486, compound
Reaction equation
[CH3:1][O:2][C:3]1[C:4]([O:17][CH3:18])=[CH:5][C:6]2[CH:12]([CH2:13][CH2:14]Cl)[O:11][CH2:10][CH2:9][CH2:8][C:7]=2[CH:16]=1.[Cl:19][C:20]1[CH:21]=[C:22]([N:26]2[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]2)[CH:23]=[CH:24][CH:25]=1>C(O)CO.C1(C)C=CC=CC=1>[CH3:1][O:2][C:3]1[C:4]([O:17][CH3:18])=[CH:5][C:6]2[CH:12]([CH2:13][CH2:14][N:29]3[CH2:28][CH2:27][N:26]([C:22]4[CH:23]=[CH:24][CH:25]=[C:20]([Cl:19])[CH:21]=4)[CH2:31][CH2:30]3)[O:11][CH2:10][CH2:9][CH2:8][C:7]=2[CH:16]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of 2.00 g (7.39 mmol) of 2-[(1,3,4,5-tetrahydro-7,8-dimethoxy-2-benzoxepin-1-yl)]ethyl chloride and 2.8 g (14.5 mmol) of 1-(3-chlorophenyl)piperazine is stirred at 85° for 36 hours in 1 ml of ethylene glycol and 10 ml of toluene. Excess toluene is added and the solids are removed by filtration from the warm solution. The organic phase is concentrated. The product was recrystallized from CH2Cl2 and toluene to give 1.09 g of product, m.p. 125°-126°.
Workup
- customthe solids are removed by filtration from the warm solution
- concentrationThe organic phase is concentrated
- customThe product was recrystallized from CH2Cl2 and toluene
Sources & evidence
- ORD record
- ord-28deaae626674bdba73cfcdfa8b1331e
- Source dataset
- uspto-grants-1982_10
- Patent number
- US04352805
Reaction notes
Loading…